Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

NCT00077311 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Anemia
Drug/Agent Toxicity by Tissue/Organ
Lung Cancer
Neutropenia

Interventions

BIOLOGICAL: darbepoetin alfa
BIOLOGICAL: pegfilgrastim
DRUG: cisplatin
DRUG: docetaxel
DRUG: BNP7787

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]